In December 2012, a Cochrane Review brought together the results of clinical trials that had looked at the effects of blood-clot promoting drugs on patients who were bleeding. The review was dominated by the large, CRASH-2 trial. In this podcast, Mike Clarke speaks with Ian Roberts, from the London School of Hygiene and Tropical Medicine in England, about both the trial and the review.